[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"eustachian-tube-dysfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:eustachian-tube-dysfunction":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,47,74,98,118,146,173],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100638123","active-vs-passive-vr-during-office-based-ent-procedures-100638123",false,"NCT07599826","Active vs. Passive VR During Office-based ENT Procedures","Active vs. Passive Virtual Reality for Reducing Pain and Anxiety During Office-based ENT Procedures","Inclusion Criteria Active and Passive VR:\n\n* Individuals 18 years old and older are included\n* Individuals undergoing the following common office-based ENT procedures: turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation (Rhineaer\u002FVivaer), nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection\n* Able to consent\n* English speaking\n\nExclusion Criteria Active VR:\n\n* History of neurologic or seizure disorder, developmental delay, uncorrected visual impairment, motion sickness, vertigo, or inability to use a handheld controller\n* Any records flagged \"break the glass\" or \"research opt out.\"\n\nExclusion Criteria Passive VR:\n\n* History of neurologic or seizure disorder, developmental delay, uncorrected visual impairment, motion sickness, or vertigo\n* Any records flagged \"break the glass\" or \"research opt out.\"","ALL","18 Years",{"count":19,"type":20},132,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of this research is to evaluate whether active virtual reality reduces pain and anxiety more effectively than passive virtual reality during office-based ENT procedures. The main procedures include exposure to virtual reality (passive calming scenery or interactive puzzle game) via Paperplane Therapeutics software with VR headset or glasses during common in-office ENT procedures, participant self-report surveys (GAD-7, PHQ-9, PEG, VAS, SUDS, Likert, experience questions), and physician post-procedure survey. The study will enroll individuals 18 years or older who are scheduled to undergo common office-based ENT procedures (turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation, nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection) at Cedars Sinai.",[26,27,28,29,30,31,32,33],"Pain","Anxiety","Chronic Rhinosinusitis (CRS)","Nasal Obstruction","Nasal Polyp","Eustachian Tube Dysfunction","Dysphonia","Subglottic Stenosis (SGS)","NOT_YET_RECRUITING","2026-05-14",{"date":37,"type":38},"2026-05-20","ACTUAL",{"date":40,"type":20},"2026-06",{"date":42,"type":20},"2027-12",{"name":44,"class":45},"Cedars-Sinai Medical Center","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":16,"minAge":17,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":21,"phases":58,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},"100460443","phase-2-effect-of-novel-exhalational-delivery-system-with-fluticasone-eds-flu-on-eustachian-tube-dysfunction-etd-100460443","NCT05275686","Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) in a Multi-center, Double-Blinded, Placebo-controlled Trial","Inclusion Criteria:\n\n* Age greater than or equal to 18 years old, \\\u003C80 years old\n* Chronic Eustachian tube dysfunction defined as:\n\n  * Symptoms in one or both ears \\> 3 months AND\n  * ETDQ-7 score \\>14.5 AND\n  * Type B, C, or As tympanometry\n* Female subjects of childbearing potential must have a negative urine pregnancy test at screening and throughout the study duration.\n\nExclusion Criteria:\n\n* Age \\\u003C18 years old\n* Known history of otologic surgery (excluding myringotomy or myringotomy tubes)\n* Use of any additional intranasal medication\n* Tympanic membrane perforation\n* Adhesive otitis media\n* Cholesteatoma or significant retraction pocket\n* Middle ear effusion\n* Nasopharyngeal tumor\n* Any history of head and neck cancer\n* Any history of head and neck irradiation\n* Any history of temporomandibular disorder or prior surgery to the temporomandibular joint\n* Any medical condition that the investigator deems inappropriate for enrollment",true,"80 Years",{"count":57,"type":20},80,[59],"PHASE2","Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel, commercially available nasal spray delivery system is available now for fluticasone that improves its delivery to the nasopharynx. The hypothesis of this study is that fluticasone using the novel spray system is effective for Eustachian tube dysfunction (ETD).",[31],[31,63],"Fluticasone","RECRUITING","2026-03-09",{"date":67,"type":38},"2026-03-11",{"date":69,"type":38},"2022-04-20",{"date":71,"type":20},"2027-12-31",{"name":44,"class":45},4,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":16,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":4,"studyType":21,"phases":85,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":46},"100611130","buteyko-breathing-and-approach-of-smoking-hygiene-effects-on-dysfucntion-of-eustachian-tube-and-lung-functions-100611130","NCT07236580","Buteyko Breathing and Approach of Smoking Hygiene: Effects on Dysfucntion of Eustachian Tube and Lung Functions","Is There Efficacy of Adding Buteyko Breathing to Approach of Smoking Hygiene on Dysfucntion of Eustachian Tube and Lung Functions in Adolescnets Who Are Passively Exposed to Tobacco Smoke?","Inclusion Criteria:\n\n* Dysfucntion of Eustachian Tube (obstructive chronic form)\n* adolescents with passive tobacco exposure from smoking parent or household member\n* adolscent participants whose parents approve the participation\n\nExclusion Criteria:\n\n* cardiac problem\n* chest disease\n* renal\u002Fhepatic disease","13 Years","17 Years",{"count":84,"type":20},40,[23],"adolescents are usually exposed to tobacco smoke passively. this can reduce their lung functions and negatively impact functions of Eustachian tube. The solution is to lower rates to tobacco exposure and use the support of Buteyko Breathing",[88,31],"Tobacco Smoking","2025-11-15",{"date":91,"type":38},"2025-11-19",{"date":93,"type":38},"2025-09-15",{"date":95,"type":20},"2026-06-15",{"name":97,"class":45},"Cairo University",{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":102,"acronym":4,"eligibilityCriteria":103,"healthyVolunteers":11,"sex":16,"minAge":104,"maxAge":105,"enrollmentInfo":106,"targetDuration":4,"studyType":21,"phases":107,"briefSummary":108,"conditions":109,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":46},"100607817","efficacy-of-buteyko-breathing-in-seniors-with-chronic-eustachian-tube-dysfunction-100607817","NCT07193485","Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction","Inclusion Criteria:\n\n* Eustachian Tube Dysfunction (chronic obstructive form)\n* unilateral ear affetion\n* senior patients\n* chronci affection more than 3 months\n\nExclusion Criteria:\n\n* obesity\n* cardiac probelms repsiratory problems","65 Years","75 Years",{"count":84,"type":20},[23],"Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective",[31],"2025-09-18",{"date":112,"type":38},"2025-09-25",{"date":114,"type":38},"2025-05-12",{"date":116,"type":20},"2025-10-10",{"name":97,"class":45},{"id":119,"slug":120,"hasResults":11,"nctId":121,"briefTitle":122,"officialTitle":123,"acronym":4,"eligibilityCriteria":124,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":125,"targetDuration":4,"studyType":21,"phases":127,"briefSummary":128,"conditions":129,"keywords":131,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":145},"100494517","efficacy-of-balloon-dilation-of-the-eustachian-tube-in-eustachian-tube-dilatory-dysfunction-100494517","NCT05719207","Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction","Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction: a Randomized, Sham-controlled Trial","Inclusion Criteria (Chronic ETDD):\n\n* \\>3 months of symptoms of ETDD (otalgia, ear pressure, muffled hearing, tinnitus, cracking or popping, feeling clogged) persistent at enrollment\n* Persistence of symptoms despite \\>4 weeks INCS or \\>7d course of systemic steroid within 6 months from enrollment\n* Documented Type B or C tympanogram at or within 6 months from enrollment\n* ETDQ7 ≥ 2.1 at enrollment\n\nInclusion criteria (baro-challenge ETDD):\n\n* \\>12 months of baro-challenge induced symptoms occurring at least every 4 months within the past year\n* Symptoms include otalgia, ear pressure, muffled hearing, tinnitus, cracking or popping, feeling clogged, vertigo, or facial nerve palsy, which resolve within 3 days of pressure equalization.\n* Failure of at least one of: topical\u002Foral decongestant, pneumatization device, and\u002For pressure relief ear plugs.\n\nExclusion Criteria:\n\n* Signs\u002Fsymptoms of patulous eustachian tube dysfunction (autophony, tympanic membrane movement with breathing)\n* Adjunctive surgical procedure needed (ex. septoplasty, tympanostomy tube)\n* Presence of a tympanic membrane (TM) perforation or tympanostomy tube\n* Fluctuating SNHL, AOM, grade IV TM retraction, or tympanosclerosis of \\>50% of the TM\n* Uncontrolled sino-nasal disease, reflux, TMJ disorder, immunodeficiency, or allergies\n* Known ICA dehiscence of the bony ET of the symptomatic ear\n* Recent head and neck surgery within the past 3 months or planned procedure during study\n* History of radiation to the head and neck\n* History of craniofacial abnormality\n* Prior ET intervention\n* Psychiatric condition or cognitive impairment which precludes capacity to consent.",{"count":126,"type":20},76,[23],"This study is being conducted to learn more about a procedure, balloon dilation of the eustachian tube, in treating patients with eustachian tube dysfunction. Traditionally, eustachian tube dysfunction is treated with nasal steroid sprays and decongestants, or by placement of ear tubes. However, current evidence suggest that medical options are ineffective, and placement of ear tubes is not risk-free. The investigators are carrying out this research study with the following goals:\n\n1. Determine if balloon dilation of the eustachian tube is superior to a placebo procedure in treating patients with eustachian tube dilatory dysfunction\n2. Identify patient variables associated with positive response to balloon dilation of the eustachian tube\n3. Re-demonstrate the safety of balloon dilation of the eustachian tube\n\nWhat does participation in this study involve? Participants in this study will:\n\n* Agree to be randomly assigned to undergo either: balloon dilation of the eustachian tube, or a placebo procedure, with the option to undergo dilation of the eustachian tube 6 weeks later\n* Agree to allowing the investigators access to their personal health information\n* Complete the following assessments and questionnaires in clinic before undergoing balloon dilation or placebo procedure:\n\n  * A questionnaire to assess your eustachian tube dysfunction\n  * An assessment of the movement of your ear drum (tympanogram)\n  * A hearing test (audiogram)\n  * A questionnaire to assess the impact of eustachian tube dysfunction on work\u002Factivity\n  * A questionnaire to assess overall health-related quality of life\n  * An assessment of the ability to equalize middle ear pressure(s)\n  * Visual examination of the ear drums\n* Repeat the above assessments and questionnaires over the course of four follow-up appointments at 6-, 24-, and 52-weeks after the procedure.",[31,130],"Barotitis",[132,133,134,135],"BDET","ETD","ETDD","baro-challenge","2025-03-31",{"date":138,"type":38},"2025-04-03",{"date":140,"type":38},"2023-06-25",{"date":142,"type":20},"2025-12-01",{"name":144,"class":45},"University of Calgary",2,{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":152,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":21,"phases":157,"briefSummary":158,"conditions":159,"keywords":160,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":4},"100515964","long-term-assessment-of-balloon-eustachian-tuboplasty-for-obstructive-eustachian-tube-disease-100515964","NCT05998356","Long-term Assessment of Balloon Eustachian Tuboplasty for Obstructive Eustachian Tube Disease","Long-term Assessment of Balloon Eustachian Tuboplasty for Obstructive Eustachian Tube Disease: A Multicenter Single-blinded Randomized Controlled Study","LASt-BET","Inclusion Criteria:\n\n* Aged between 18 and 85 years\n* Clinical symptoms of OETD with Eustachian tubal score less or equal to 7\u002F14\n* Failure of well conducted medical treatment (GERD, allergy, rhinosinusitis) including pressure equalization device used for 1 month or more\n* ASA score 1 or 2 (ASA : American Society of Anesthesiologists)\n\nExclusion Criteria:\n\n* Palatal cleft\n* Anatomical anomaly of pharyngeal Eustachian tube ostium on the treated side\n* Medical history of nasopharyngeal radiotherapy\n* Medical history of middle ear surgery (except myringotomy and\u002For tympanostomy tube)\n* Eardrum perforation in the treated side\n* Contraindication of general anesthesia, or major risk of general anesthesia including ASA scores of 3 and 4\n* Major nasal obstruction ipsilateral to the Eustachian tube to treat\n* Medical history of previous Eustachian Tube Dilation\n* Pregnant or nursing woman, or in childbearing age and not willing to use contraception\n* Inclusion in another interventional clinical trial\n* Protected and vulnerable adult\n* Not covered by Health insurance\n* Refusal to sign informed consent form\n* Subjects unable to attend all scheduled visits or to comply with all trial procedures","85 Years",{"count":156,"type":20},96,[23],"To date, more than 130 000 Balloon Eustachian Tuboplasty (BET) procedures have been performed worldwide. This procedure is proposed in case of Obstructive Eustachian Tube Dysfunction (OETD) with or without chronic otitis media. However, the effectiveness of this procedure is still discussed amongst otolaryngologist. Most of studies,were open label prospective studies comparing Eustachian tube function before and after surgical treatment. A recent meta-analysis suggests that BET procedure improves postoperative Eustachian tube function, but high-level evidence is still lacking. In this project, the investigators propose to perform the first blinded randomized controlled trial procedure to assess the changes of Eustachian tube function after BET in a population of subjects with chronic OETD with or without chronic otitis. Prognosis factors of efficacy will be also investigated during the study.",[31],[161,162,163],"Eustachian tube","Balloon Eustachian Tuboplasty","Eustachian Tubal Score","2023-09-19",{"date":166,"type":38},"2023-09-21",{"date":168,"type":20},"2023-10-01",{"date":170,"type":20},"2027-01-01",{"name":172,"class":45},"University Hospital, Montpellier",{"id":174,"slug":175,"hasResults":11,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":4,"eligibilityCriteria":179,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":180,"enrollmentInfo":181,"targetDuration":4,"studyType":21,"phases":183,"briefSummary":184,"conditions":185,"keywords":189,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":191,"lastUpdatePostDateStruct":192,"startDateStruct":194,"completionDateStruct":196,"leadSponsor":197,"locationsCount":46},"100412050","balloon-sinuplasty-efficiency-in-maxillary-rhinosinusitis-100412050","NCT04645511","Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.","A Placebo Controlled Randomised Study of the Balloon Sinuplasty Efficiency in Chronic or Recurrent Maxillary Rhinosinusitis.","Inclusion Criteria:\n\n* Patients at least 18 years old and younger than 70 years old\n* Patients willing to participate in the study\n* Patients whose diseases fill the definitions of chronic or acute recurrent maxillary rhinosinusitis\n* Patients with chronic maxillary rhinosinusitis has not responded to a 3-month trial of topical corticosteroid treatment\n* SNOT-22 points 8 or more in chronic maxillary rhinosinusitis\n* In recurrent acute maxillary rhinosinusitis, no SNOT-22 point limits are used\n* Modified Lund-Mackay inclusion criteria in chronic rhinosinusitis group:\n\n  1. Maxillar 0-2\n  2. Anterior Ethmoid 0-2\n  3. Posterior Ethmoid 0-1\n  4. Sphenoid 0-1\n  5. Frontal 0-1\n  6. Ostiomeatal complex 0 or 2\n\nExclusion Criteria:\n\n* Chronic rhinosinusitis with nasal polyps\n* Notable inflammation in the ethmoidal, sphenoidal or frontal sinuses along with maxillary sinusitis\n* Previous nasal surgery\n* Sinonasal tumor\n* Maxillary rhinosinusitis caused by a dental problem\n* Facial pain caused by other etiologies\n* Cystic fibrosis\n* Gross immunodeficiency\n* Congenital mucociliary problems\n* Non-invasive fungal balls and invasive fungal disease\n* Systemic vasculitis and granulomatous disease\n* Severe systemic diseases\n* Malignancies\n* Pregnancy\n\nDefinitions:\n\nRecurrent acute maxillary rhinosinusitis:\n\n* 4 or more episodes (\\\u003C 12 weeks) of acute rhinosinusitis with typical symptoms per year and no persistent symptoms between the rhinosinusitis episodes (Chan and Kuhn 2009)\n* The diagnosis of the recurrent episodes of acute rhinosinusitis have been made with the following criteria:\n\n  * Increase of symptoms after 5 days or persistent symptoms after 10 days and\n  * During the episode, 2 or more symptoms, one of which should be either nasal blockage\u002Fobstruction or nasal discharge (anterior\u002Fposterior nasal drip)\n  * +\u002F- facial pain\u002Fpressure\n  * +\u002F- reduction or loss of smell (Fokkens et al. 2012) and either\n  * Signs of mucopurulent discharge primarily from the middle meatus seen in anterior rhinoscopy or nasoendoscopy and\u002For\n  * Oedema\u002Fmucosal obstruction primarily seen in the middle meatus in anterior rhinoscopy or nasoendoscopy and\u002For\n  * Signs of mucopurulent discharge seen in the nasopharynx or posterior oropharynx and\u002For\n  * Signs of acute maxillary sinusitis is seen in sinus X-rays or CT\u002FCBCT scans and\u002For\n  * Signs of acute maxillary sinusitis seen in the sinus ultrasound\n* No signs of mucosal disease at nasoendoscopy during the asymptomatic period\n* At most, minor signs of inflammation in the maxillary sinuses and\u002For ostiomeatal complex in CT\u002FCBCT scans during the asymptomatic period\n\n  * Maximum 2-3 mm mucosal thickness in maxillary sinus medial and lateral wall\n\nChronic maxillary rhinosinusitis:\n\n* Presence of typical symptoms of chronic rhinosinusitis for equal or longer than 12 weeks\n\n  * 2 or more symptoms, one of which should be either nasal blockage\u002Fobstruction or nasal discharge (anterior\u002Fposterior nasal drip)\n  * +\u002F- facial pain\u002Fpressure\n  * +\u002F- reduction or loss of smell and either\n  * Endoscopic signs of mucopurulent discharge primarily from middle meatus and\u002For\n  * Endoscopic signs of oedema\u002Fmucosal obstruction primarily in middle meatus and\u002For\n  * Inflammatory mucosal changes within the ostiomeatal complex and\u002For sinus in the CT\u002FCBCT scans and the changes are limited mainly into maxillary sinuses (Fokkens et al. 2012)\n\nThe patients are not recruited in the study while they are having an exacerbation of chronic rhinosinusitis or an ongoing acute rhinosinusitis. Neither are the follow-up visits carried out during these episodes but postponed later. This way it can be ensured that the preoperative evaluation and the follow-up evaluation correspond with each other.","69 Years",{"count":182,"type":20},120,[23],"This study is a prospective, randomized, placebo-controlled, double-blinded clinical study. The balloon sinuplasty treatment is compared to placebo effect in chronic or recurrent maxillary sinusitis. The purpose is to find out the efficacy of balloon sinuplasty of maxillary sinuses and the patients who get the best benefit from balloon sinuplasty. The investigators also want to find out if balloon sinuplasty of maxillary sinuses improves Eustachian tube dysfunction. The study is executed in the Department of Ear and Oral Diseases, Tampere University Hospital. 120 patients who have either recurrent acute or chronic rhinosinusitis without nasal polyposis and whose sinusitis is limited mainly into maxillary sinuses, are recruited in the study. The patients are allocated either into the chronic maxillary sinusitis (60 patients) or the recurrent maxillary sinusitis (60 patients) branch of the study. Then, the patients are consecutively randomized into two treatment groups in the proportion of 1 to 1: A) Balloon sinuplasty group and B) Placebo group. The treatment is performed according to the patient's group status and all the patients are followed 12 months postoperatively.\n\nThe effect of balloon sinuplasty treatment in chronic maxillary rhinosinusitis is going to be measured primarily with the Sino-Nasal Outcome Test (SNOT-22). In recurrent acute maxillary rhinosinusitis, the effect of balloon sinuplasty treatment will be measured primarily with the number of acute rhinosinusitis infections. Besides this, number of antibiotic treatments and sick leaves are inquired, Visual Analog Scale (VAS) and Eustachian Tube Dysfunction Questionnaire (ETDQ-7) are used, rhinomanometry, Cone Beam Computed Tomography (CBCT), tympanometry, tubomanometry, nasal endoscopy and general evaluation of the patients clinical ORL-status are performed. Also pre- and postoperative biopsies are taken from the middle turbinates.",[186,187,188,31],"Maxillary Sinusitis","Sinusitis, Chronic","Sinusitis Recurrent",[190],"Balloon sinuplasty","2022-10-18",{"date":193,"type":38},"2022-10-20",{"date":195,"type":38},"2021-06-01",{"date":71,"type":20},{"name":198,"class":45},"Tampere University Hospital"]